OpenAlex
PricingAboutJobs
Log inGet started
Work

Adverse Events and Safety of SARS-CoV-2 Vaccines: What’s New and What’s Next

HTML

Year: 2022
Type: review
Source: The Journal of Allergy and Clinical Immunology In Practice
DOI: 10.1016/j.jaip.2022.04.035
Authors: Kristen B. Corey, Grace Koo, Elizabeth J. Phillips
Institutions: Vanderbilt University Medical Center, Murdoch University
Language: English

Topic: SARS-CoV-2 and COVID-19 Research
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: bronze

Funders: National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Awards: Improving Prediction of Drug Action, Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors, Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis, Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study), NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
OpenAlex ID: W4229442151
FWCI: 0.269
Cites: 96
Cited by: 7
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms